These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


441 related items for PubMed ID: 9829579

  • 21. Comparison of 201Tl, 99Tcm-MIBI and 131I imaging in the follow-up of patients with well-differentiated thyroid carcinoma.
    Uğur O, Kostakoğlu L, Caner B, Güler N, Gülaldi NC, Ozmen M, Uysal U, Elahi N, Erbengi G, Bejdik C.
    Nucl Med Commun; 1996 May; 17(5):373-7. PubMed ID: 8736512
    [Abstract] [Full Text] [Related]

  • 22. Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal.
    Oyen WJ, Verhagen C, Saris E, van den Broek WJ, Pieters GF, Corsten FH.
    J Nucl Med; 2000 Apr; 41(4):643-6. PubMed ID: 10768565
    [Abstract] [Full Text] [Related]

  • 23. [Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid cancer--comparison study with 131I and 201Tl].
    Nagamachi S, Jinnouchi S, Nishii R, Flores LG, Nakahara H, Futami S, Tamura S, Toshimori H, Kawai K.
    Kaku Igaku; 2000 Mar; 37(2):89-98. PubMed ID: 10783567
    [Abstract] [Full Text] [Related]

  • 24. [A comparison of 201Tl and 99mTc-MIBI in the follow-up of differentiated thyroid carcinomas].
    Briele B, Hotze A, Kropp J, Bockisch A, Overbeck B, Grünwald F, Kaiser W, Biersack HJ.
    Nuklearmedizin; 1991 Aug; 30(4):115-24. PubMed ID: 1788076
    [Abstract] [Full Text] [Related]

  • 25. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
    Apostolopoulos DJ, Houstoulaki E, Giannakenas C, Alexandrides T, Spiliotis J, Nikiforidis G, Vlachojannis JG, Vassilakos PJ.
    J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
    [Abstract] [Full Text] [Related]

  • 26. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    Ringel MD, Balducci-Silano PL, Anderson JS, Spencer CA, Silverman J, Sparling YH, Francis GL, Burman KD, Wartofsky L, Ladenson PW, Levine MA, Tuttle RM.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
    [Abstract] [Full Text] [Related]

  • 27. Thyroid carcinoma: iodine-131-negative whole-body scan reverses to positive after a combination of thyrogen stimulation and withdrawal.
    Kasner DL, Spieth ME, Starkman ME, Zdor-North D.
    Clin Nucl Med; 2002 Nov; 27(11):772-80. PubMed ID: 12394123
    [Abstract] [Full Text] [Related]

  • 28. Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary results.
    Gallowitsch HJ, Kresnik E, Mikosch P, Pipam W, Gomez I, Lind P.
    Nuklearmedizin; 1996 Dec; 35(6):230-5. PubMed ID: 8976503
    [Abstract] [Full Text] [Related]

  • 29. [Results of radioiodine therapy in patients with pulmonary metastases of differentiated thyroid cancer].
    Ono Y, Yamamoto Y, Nishiyama Y, Nakano S, Takahashi K, Kawasaki Y, Satoh K, Ohkawa M, Tanabe M.
    Kaku Igaku; 2000 Nov; 37(6):661-70. PubMed ID: 11193452
    [Abstract] [Full Text] [Related]

  • 30. Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging.
    Soricelli A, Cuocolo A, Varrone A, Discepolo A, Tedeschi E, Mainenti PP, Grivet-Fojaja MR, Covelli EM, Postiglione A, Salvatore M.
    J Nucl Med; 1998 May; 39(5):802-6. PubMed ID: 9591579
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Follow-up of differentiated thyroid cancer.
    Pacini F.
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551
    [Abstract] [Full Text] [Related]

  • 33. Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans.
    Klain M, Maurea S, Cuocolo A, Colao A, Marzano L, Lombardi G, Salvatore M.
    Eur J Nucl Med; 1996 Dec; 23(12):1568-74. PubMed ID: 8929309
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.
    Filesi M, Signore A, Ventroni G, Melacrinis FF, Ronga G.
    J Nucl Med; 1998 Sep; 39(9):1542-6. PubMed ID: 9744339
    [Abstract] [Full Text] [Related]

  • 36. Scintigraphy with 201Tl for detection of thyroid cancer metastases.
    Piers DA, Sluiter WJ, Willemse PH, Doorenbos H.
    Eur J Nucl Med; 1982 Sep; 7(11):515-7. PubMed ID: 7173250
    [Abstract] [Full Text] [Related]

  • 37. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
    Lubin E, Mechlis-Frish S, Zatz S, Shimoni A, Segal K, Avraham A, Levy R, Feinmesser R.
    J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
    [Abstract] [Full Text] [Related]

  • 38. [99mTc Tetrofosmin in diagnosis of distant metastases from differentiated thyroid cancer].
    Drac-Kaniewska J, Kozłowicz-Gudzińska I, Tomaszewicz-Kubasik H, Kaniewski M, Godlewska P, Czetwertyńska M, Chaładaj-Kujawska A.
    Wiad Lek; 2001 Feb; 54 Suppl 1():357-62. PubMed ID: 12182048
    [Abstract] [Full Text] [Related]

  • 39. Usefulness of technetium-99m hydroxymethylene diphosphonate scans in localizing bone metastases of differentiated thyroid carcinoma.
    Tenenbaum F, Schlumberger M, Bonnin F, Lumbroso J, Aubert B, Benali H, Parmentier C.
    Eur J Nucl Med; 1993 Dec; 20(12):1168-74. PubMed ID: 8299652
    [Abstract] [Full Text] [Related]

  • 40. Lung metastases in patients with differentiated thyroid carcinoma and evaluation of response to radioiodine therapy.
    Kalender E, Zeki Celen Y, Elboga U, Deniz Demir H, Yilmaz M.
    Rev Esp Med Nucl Imagen Mol; 2012 Dec; 31(6):328-31. PubMed ID: 23084016
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.